Do yourself a favour and take a look at the Scientific advisory board of the company, and you will find the answer. As a diabetis pill development company, this board looks great for me.
If you do not have any confidence in the ORMP diabetis project, why spend time posting. I'm a Dane and we have a healthy company Novo Nordic, who is very strong in traditional diabetis treatment. You can find it under the symbol NVO. Maybe NVO match your investment interests and opinion.
ORMP is developing a pill against diabetis, not a brain surgery robbot. If you are one of the silly shorts, who made a wrong decision listning to Adam Feuerstein and the othe bozoes, you can find at the SeekingAlpha posts. Take your loss now before it's to late.
Thanks for the summary. I will advise all ORMP investors to see/listen to the Jefferies presentation. My opinion a very positive/optimistic case. GLTA.
Take a look at the volume during the last month. Do you really think it's Wall Street trading in such a ridiculous volume? :D
Adam Fraudstein fom The Street wrong again. Do not listen to this guy.
Samsung's fingerprint biometric solution - swipe technology - has been outdated for several years. Do you call using this kind of technology innovative? :D
Let's wait until you hear news from Adam Fraudstein from the Street, this time I am sure people will just ignore the jerk.
The most important to notice in this article is the last three lines, where the author writ: " I am long MKND" :D